Cepheid's Product Sales up 2 Percent in Q2 | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid reported after the close of the market on Thursday that its total revenues fell around 3 percent, but its product sales were up 2 percent, for the second quarter of 2009.

The Sunnyvale, Calif.-based molecular diagnostics firm brought in total revenues of $41 million for the three months ended June 30, compared to $42.1 million for the second quarter of 2008. Its product sales increased to $39.6 million from $39 million, while "other" revenues fell to $1.5 million from $3.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.